Syntax Expands Its SAP® Global Operations Certifications

Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has received a Golden Certificate from SAP® in recognition of 10 consecutive ...

Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...

Syntax Bio expands Series A to $14.4M, inks Mayo Clinic collaboration

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.
Business Wire

Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...
The Caledonian-Record

Syntax Bio Announces Expanded Series A and Leadership Appointments

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...
dbta

Syntax Systems Acquires Beyond Technologies to Further Support SAP

Syntax Systems, a global technology solutions and services provider for cloud application implementation and management, has officially acquired Montreal-based Beyond Technologies, enabling the ...

Syntax Bio expands Series A to $14.4M, adds leadership and board members

Syntax Bio, a privately held synthetic biology company focused on cell therapies, on Sunday said it expanded its Series A financing round to $14.4 million, bringing total funding raised to more than ...